Hep Email Update Latest Data Show Dramatic Rise in Hepatitis A, Smaller Increase in Hep C Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment. Advertisement Nonobese People Account for 40% of Global NAFLD Population A fifth of the worldwide population with fatty liver disease consists of lean people. Public Health Experts Fear a Hasty FDA Signoff on Vaccine The FDA must approve any coronavirus vaccine before it’s widely distributed, but political pressure could cloud the decision. Experts Suggest Regular COVID-19 Testing of College Students Lower-quality coronavirus tests, mask wearing and frequent handwashing can help control coronavirus infections on campuses. #Coronavirus Get the latest updates! Staying Alive In honor of Hep commemorating 10 years, we are spotlighting 10 inspiring activists: Sherri Lewis continues to sing out loud for people living with hep C. Advertisement Treatment News Nonobese People Account for 40% of Global NAFLD Population Latest Data Show Dramatic Rise in Hepatitis A, Smaller Increase in Hep C NASH Is the Second Leading Indication for Liver Transplants More Physical Activity Tied to Lower Fatty Liver Disease Mortality Egrifta Improves Liver Health in People With HIV Company Halts Leading NASH Drug but Another Shows Promise Newsfeed Experts Suggest Regular COVID-19 Testing of College Students Public Health Experts Fear a Hasty FDA Signoff on Vaccine Nonobese People Account for 40% of Global NAFLD Population Structural Racism Puts Latinos at Risk for COVID-19 NASH Is the Second Leading Indication for Liver Transplants More Physical Activity Tied to Lower Fatty Liver Disease Mortality Treatment News Nonobese People Account for 40% of Global NAFLD Population Latest Data Show Dramatic Rise in Hepatitis A, Smaller Increase in Hep C NASH Is the Second Leading Indication for Liver Transplants More Physical Activity Tied to Lower Fatty Liver Disease Mortality Egrifta Improves Liver Health in People With HIV Company Halts Leading NASH Drug but Another Shows Promise Newsfeed Experts Suggest Regular COVID-19 Testing of College Students Public Health Experts Fear a Hasty FDA Signoff on Vaccine Nonobese People Account for 40% of Global NAFLD Population Structural Racism Puts Latinos at Risk for COVID-19 NASH Is the Second Leading Indication for Liver Transplants More Physical Activity Tied to Lower Fatty Liver Disease Mortality

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: